| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 131,514 | 72,543 | | Cost of Revenue | 30,184 | 16,249 | | | Gross Profit | 101,330 | 56,294 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 2,817 | 1,477 | | Non Recurring |
-
|
-
| | Others | 25,031 | 13,109 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 73,482 | 41,708 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,229 | (3,072) | | Earnings Before Interest And Taxes | 74,711 | 38,636 | | Interest Expense | 25,448 | 10,809 | | Income Before Tax | 49,263 | 27,827 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 49,263 | 27,827 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 49,263 | 27,827 | | Preferred Stock And Other Adjustments |
-
| (6,256) | | | Net Income Applicable To Common Shares | $49,263 | $21,571 |
|
0.29% Nasdaq 
Income Statement
